|
Integra Lifesciences Holdings Corporation (IART) DCF Valoración
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Integra LifeSciences Holdings Corporation (IART) Bundle
Diseñada para la precisión, nuestra calculadora DCF (IART) le permite evaluar la valoración de Intepra Lifesciences Holdings Corporation utilizando datos financieros del mundo real y proporciona flexibilidad completa para modificar todos los parámetros esenciales para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,517.6 | 1,371.9 | 1,542.4 | 1,557.7 | 1,541.6 | 1,552.3 | 1,563.1 | 1,574.0 | 1,585.0 | 1,596.0 |
| Revenue Growth, % | 0 | -9.6 | 12.43 | 0.98661 | -1.03 | 0.69684 | 0.69684 | 0.69684 | 0.69684 | 0.69684 |
| EBITDA | 231.0 | 267.9 | 366.3 | 391.1 | 274.0 | 314.8 | 317.0 | 319.2 | 321.4 | 323.6 |
| EBITDA, % | 15.22 | 19.53 | 23.75 | 25.11 | 17.77 | 20.28 | 20.28 | 20.28 | 20.28 | 20.28 |
| Depreciation | 114.7 | 119.0 | 123.7 | 121.1 | 123.5 | 124.3 | 125.2 | 126.0 | 126.9 | 127.8 |
| Depreciation, % | 7.56 | 8.67 | 8.02 | 7.78 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 |
| EBIT | 116.3 | 148.9 | 242.7 | 270.0 | 150.5 | 190.5 | 191.8 | 193.1 | 194.5 | 195.8 |
| EBIT, % | 7.67 | 10.86 | 15.73 | 17.33 | 9.76 | 12.27 | 12.27 | 12.27 | 12.27 | 12.27 |
| Total Cash | 198.9 | 470.2 | 513.4 | 456.7 | 309.1 | 403.7 | 406.5 | 409.4 | 412.2 | 415.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 275.3 | 225.5 | 231.8 | 263.5 | 259.3 | 258.8 | 260.6 | 262.4 | 264.2 | 266.0 |
| Account Receivables, % | 18.14 | 16.44 | 15.03 | 16.91 | 16.82 | 16.67 | 16.67 | 16.67 | 16.67 | 16.67 |
| Inventories | 316.1 | 310.1 | 317.4 | 324.6 | 389.6 | 341.9 | 344.3 | 346.7 | 349.1 | 351.5 |
| Inventories, % | 20.83 | 22.61 | 20.58 | 20.84 | 25.27 | 22.02 | 22.02 | 22.02 | 22.02 | 22.02 |
| Accounts Payable | 113.1 | 54.6 | 61.8 | 102.1 | 92.3 | 86.9 | 87.5 | 88.1 | 88.7 | 89.3 |
| Accounts Payable, % | 7.45 | 3.98 | 4.01 | 6.55 | 5.99 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 |
| Capital Expenditure | -134.5 | -63.9 | -48.1 | -47.1 | -66.9 | -74.5 | -75.0 | -75.6 | -76.1 | -76.6 |
| Capital Expenditure, % | -8.87 | -4.66 | -3.12 | -3.02 | -4.34 | -4.8 | -4.8 | -4.8 | -4.8 | -4.8 |
| Tax Rate, % | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 | 16.44 |
| EBITAT | 97.2 | 213.2 | 191.1 | 227.9 | 125.8 | 163.9 | 165.0 | 166.2 | 167.4 | 168.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -400.9 | 265.6 | 260.4 | 303.4 | 111.7 | 256.5 | 211.6 | 213.1 | 214.6 | 216.1 |
| WACC, % | 6.74 | 7.09 | 6.63 | 6.76 | 6.74 | 6.79 | 6.79 | 6.79 | 6.79 | 6.79 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 921.3 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 224 | |||||||||
| Terminal Value | 6,796 | |||||||||
| Present Terminal Value | 4,893 | |||||||||
| Enterprise Value | 5,814 | |||||||||
| Net Debt | 1,405 | |||||||||
| Equity Value | 4,409 | |||||||||
| Diluted Shares Outstanding, MM | 80 | |||||||||
| Equity Value Per Share | 54.88 |
What You Will Get
- Real IART Financial Data: Pre-filled with Integra LifeSciences' historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Integra LifeSciences' intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for Integra LifeSciences Holdings Corporation (IART).
- Tailored Forecast Inputs: Modify highlighted cells for key assumptions such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Enjoy automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Utilize user-friendly charts and summaries to effectively visualize your valuation outcomes.
- Designed for All Users: An intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file for Integra LifeSciences Holdings Corporation (IART).
- Step 2: Review the pre-filled financial data and forecasts specific to Integra LifeSciences.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Integra LifeSciences Holdings Corporation (IART)?
- Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for (IART).
- Customizable Inputs: Modify yellow-highlighted cells to explore different scenarios for (IART).
- Detailed Insights: Automatically calculates the intrinsic value and Net Present Value specific to (IART).
- Preloaded Data: Access historical and forecasted data for (IART) to ensure accurate analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on (IART).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Integra LifeSciences stock (IART).
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Integra LifeSciences (IART).
- Consultants: Deliver professional valuation insights to clients quickly and accurately regarding Integra LifeSciences (IART).
- Business Owners: Understand how large companies like Integra LifeSciences (IART) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Integra LifeSciences (IART).
What the Template Contains
- Pre-Filled DCF Model: Integra LifeSciences' financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Integra LifeSciences' profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.